Best Functional Service Providers (FSP) for Clinical Trials

Who this guide is for

This guide is for outsourcing leads, heads of clinical operations and biometrics managers at sponsors that run their own trials and want to add capacity function by function rather than hand whole studies to a CRO. If you are weighing the best FSP providers clinical trials teams can embed alongside their own staff, the real decision is who will supply people, processes and output while oversight stays in-house. The list above shows which providers in our directory record a functional service model. It does not tell you how a provider performs in your systems, how well it keeps its staff, or whether it can fill your roles in your regions. Vendor scores on Clinical Vendor Compare come only from published platform reviews; a vendor with no reviews shows no score.

What a functional service provider does — and when you need one

A functional service provider (FSP) supplies dedicated teams to run specific functions inside a sponsor’s development organisation. Rather than owning a whole study, as in full-service outsourcing (often called FSO), an FSP takes on a defined function — monitoring, data management, statistical programming — across a portfolio, usually working to the sponsor’s standards and in the sponsor’s systems. The sponsor keeps strategy, decision rights and oversight; the provider supplies trained people, line management and the processes that keep them productive.

The boundaries matter. A full-service CRO owns delivery of a study end to end, largely in its own systems. A staffing agency places individuals but does not manage their output or quality. A niche specialist may deliver a single function on a project basis without portfolio-level resourcing. Many CROs sell both models, so check which delivery organisation you are buying from.

Typical triggers are a portfolio that has outgrown internal headcount, a need for consistent standards across studies, or a hiring freeze. An FSP is usually the wrong fit for an early-stage biotech with no internal SOPs, systems or functional leads to direct the work.

The main FSP service lines

• Clinical operations — CRAs, in-house CRAs, site start-up specialists and trial assistants working inside the sponsor’s monitoring plan and CTMS.
• Biostatistics and programming — statisticians and statistical programmers producing analysis plans, CDISC SDTM and ADaM datasets, and tables, listings and figures.
• Data management — database build, edit checks, data cleaning, external data reconciliation and database lock in the sponsor’s EDC.
• Medical writing — protocols, investigator brochures, clinical study reports and submission summaries.
• Pharmacovigilance — case processing, ICSR reporting to the E2B(R3) standard, signal management support and aggregate reports such as DSURs.
• Regulatory — clinical trial applications, eCTD publishing and lifecycle maintenance of submissions.

How to evaluate a functional service provider

Depth in the function you are buying

A provider that is strong in monitoring may be thin in statistical programming. Meet functional leads, not only business development, and request anonymised CVs at the grades you expect. For biometrics, ask how programmers are trained in CDISC standards and who performs independent QC programming; for pharmacovigilance, ask who carries out medical review.

Fit with your systems and SOPs

Most FSP engagements run either on the sponsor’s SOPs and systems or on the provider’s processes under sponsor oversight. The choice affects training burden, inspection readiness and how easily you can change provider later. Ask how staff are onboarded to your SOPs, where training records are kept, and how access to validated systems is controlled where 21 CFR Part 11 applies.

Resourcing, ramp-up and flexibility

The promise of FSP is elastic capacity, so test it. Ask how roles are sourced — existing bench, redeployment or new hires — what the measured time to fill is for your grades, and how ramp-down and notice work. Ask whether staff will be employees or contractors, which matters for continuity and, in the UK, for off-payroll working rules.

Staff retention and knowledge retention

Turnover is the main way FSP value leaks away: every departure takes study history, system know-how and working relationships with it. Ask for attrition data on comparable programmes, the provider’s retention approach and its knowledge-transfer process — handover templates, overlap periods, study-specific work instructions and backfill commitments. Insist that the knowledge base lives in your systems, so it survives a team change or a change of provider.

Governance and sponsor oversight

Under ICH E6(R3) a sponsor may transfer trial-related activities to a service provider, but it keeps responsibility for the trial and must oversee what it has transferred. Look for tiered governance — operational meetings, a joint steering committee and named executive sponsors — with escalation routes, a responsibilities matrix per function and a clear issue and CAPA process. Ask to see a redacted governance charter from a current engagement.

Quality and performance measurement

Agree metrics before signature: quality (rework, query trends, audit and inspection findings), timeliness against milestones, and resourcing (time to fill, turnover). Ask who produces the reports and whether metrics can be tied to service credits. Be wary of a provider that reports only utilisation, which measures its revenue rather than your outcomes.

Regional reach and UK delivery

If you need a functional service provider CRO UK sites can work with day to day, check where the people will actually sit. Ask about UK-based CRAs for MHRA-regulated studies, familiarity with HRA and NHS research approvals, and how UK GDPR and international data transfers are handled when biometrics or safety teams work offshore. Where an FSP takes over an existing team, TUPE may apply, so take employment advice early.

Functional service providers at a glance

The table below sets the shortlisted providers side by side on the fields buyers most often filter on: vendor type, service model, footprint, headquarters, study phases and therapeutic areas.

The fields come from each vendor’s Clinical Vendor Compare profile. MedSource and Advanced Clinical are listed with an FSP CRO service model, while Fortrea and Roivant Sciences list full-service delivery alongside FSP. Advanced Clinical and Roivant Sciences name specific therapeutic areas; the other profiles are generalist. Every profile lists global or multi-region coverage and a United States headquarters, so UK buyers should confirm where delivery teams are employed and managed.

FSP provider profiles

Ergomed CRO (MedSource)

Ergomed CRO (MedSource) is listed as a full-service CRO operating an FSP service model, with global coverage and headquarters in the USA. Its profile records mixed study phases and a generalist therapeutic focus, at the scale of specialist and mid-size global programmes. The stated best fit is sponsors looking for clinical CRO options with global reach, and listed strengths are functional service provision and clinical monitoring. Where to probe: the profile does not break down other service lines, so ask which functions beyond monitoring it staffs under an FSP model and request references from comparable embedded engagements.

Advanced Clinical

Advanced Clinical is listed as a specialist CRO with an FSP service model, covering North America, Europe, Asia and global delivery from a US headquarters. Its profile spans Phase I to Phase IV, with oncology, rare disease and dermatology named alongside generalist work. The stated best fit is programmes that need specialist therapeutic or modality expertise without a mega-CRO footprint. Listed strengths are therapeutic depth, flexibility and specialist teams. Where to probe: the profile notes its infrastructure may be narrower than that of the major full-service CROs, so test ramp-up capacity and systems support for a portfolio-wide deployment.

Fortrea

Fortrea is listed as a full-service CRO offering both full-service and FSP models, with global coverage and headquarters in the United States. Its profile covers Phase I to Phase IV on a generalist basis and points to large global programmes and hybrid delivery models. The stated best fit is programmes seeking a balance between scale and execution focus, and listed strengths are operational execution and therapeutic know-how. Where to probe: the profile notes that publicly available evidence is still maturing following its separation, so ask for references from FSP engagements delivered since.

Roivant Sciences

Roivant Sciences is listed as full-service with a full-service plus FSP model, global coverage and headquarters in the United States. Its profile covers Phase I to Phase IV across oncology, immunology, neurology, rare diseases and inflammatory disease, at medium, large and global scale. Stated fits are clinical development platforms, therapeutic-area-focused drug development and data analytics. Listed strengths include its Vant model, a data platform, therapeutic depth and a Nasdaq listing. Where to probe: the profile describes it as a drug developer first and a vendor second, not a traditional CRO, so confirm whether functional services are offered to external sponsors and on what terms.

FSP engagement and pricing models

FSP work is usually contracted through a master services agreement with function-level work orders. The commercial model shapes behaviour as much as cost, so choose it deliberately.

FTE-based

You buy dedicated full-time-equivalent roles at agreed rates by grade and location. It is simple to budget and easy to redirect between studies, but it pays for headcount rather than output, so you carry productivity risk and must manage utilisation yourself.

Unit-based

You pay per defined unit, such as a monitoring visit, a processed safety case or a programmed output. Cost tracks activity and productivity risk moves to the provider, but unit definitions must be tight and change control disciplined.

Output- or outcome-based

Payment is linked to deliverables or milestones, often with service credits against agreed quality and timeliness metrics. It aligns interests most closely but needs mature metrics and baseline data, and providers will price in the risk.

Hybrid FSP-FSO models

Many sponsors combine approaches: full-service outsourcing for selected studies or regions, FSP teams for functions they want standardised across the portfolio, or an FTE core with unit-based pricing for peaks. Hybrids add flexibility but create interfaces, so define who owns each handoff, such as data transfers from an FSO-run study into an FSP biometrics team.

The main cost drivers are seniority mix, resource location, ramp-up and training on your SOPs and systems, turnover and backfill, system licences, governance overhead and any minimum-volume or notice commitments. Ask for rate cards by grade and region, and model the cost of turnover explicitly.

Questions to put in your FSP RFP

• Which functions do you deliver under an FSP model today, and is FSP run separately from your full-service business?
• Will staff be your employees or contractors, and where will each role be based?
• How do you source roles, and what is your measured time to fill for the grades we need?
• What has attrition been on comparable FSP programmes over the past year, and how do you calculate it?
• What happens when a team member leaves: handover process, overlap period and contractual backfill commitments?
• Can your teams work on our SOPs and in our validated systems, and how is that onboarding documented?
• How will you help us evidence sponsor oversight under ICH E6(R3), and what governance tiers do you propose?
• Which quality and timeliness metrics will you report, how often, and can they be tied to service credits?
• How do you handle UK GDPR and international data transfers if any of the team works outside the UK?
• What does exit look like — transition assistance, knowledge handover, and how TUPE would be handled if staff move to us or a successor?

Due-diligence red flags

• A proposal that quotes rates but cannot name the functional lead who will run your team.
• Reluctance to share attrition data or to commit to backfill and handover terms in the contract.
• Heavy reliance on contractors for roles you expect to be stable, with no continuity plan.
• Metrics limited to utilisation or headcount rather than quality and timeliness.
• Training records on your SOPs that would sit only in the provider’s systems.
• Governance that depends on a single relationship manager, with no steering or escalation routes.
• Vague unit definitions in a unit-based model, which tend to resurface as change orders.
• An FSP offer that is really a relabelled full-service team, running on the provider’s processes with little sponsor control.

Shortlist FSP providers on Clinical Vendor Compare

Start in the vendor directory and filter for providers with FSP or full-service models in your function and region. Then use compare to set your shortlist side by side. When you are ready to test the market, the sponsor RFP page lets you set out the functions, regions and engagement model you need so providers respond on the same terms. If you have worked with any of these providers under an FSP model, please write a review: first-hand accounts of staffing, retention and governance help other sponsors judge how embedded teams work in practice.